Sign Up Today and Learn More About Circle Pharma Stock
Invest in or calculate the value of your shares in Circle Pharma or other pre-IPO companies through EquityZen, part of Morgan Stanley.
Circle Pharma Stock (CIRP)
Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.
About Circle Pharma Stock
Founded
2012
Headquarters
San Francisco, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Circle Pharma Press Mentions
Stay in the know about the latest news on Circle Pharma
Which biotechs have raised new VC financing this week?
pharmaphorum • Sep 18, 2026
Series E financing at Circle Pharma to advance cyclin D1 program
bioworld • Sep 18, 2026
Circle Pharma Raises $92.5 Million Series E To Advance Cyclin D1 Cancer Drug CID-165 Into Clinical Development
pulse2 • Sep 17, 2026
Circle Pharma raises $92.5 million to advance cyclin D1 inhibitor toward clinic
thepharmaletter • Sep 17, 2026
Circle Pharma Raises $92.5M in Series E Funding
finsmes • Sep 17, 2026
Circle Pharma Management
Leadership team at Circle Pharma
Board Member
Thilo Schroeder
Board Member
Peter Svennilson
Join now and verify your accreditation status to gain access to:
- Circle Pharma Current Valuation
- Circle Pharma Stock Price
- Circle Pharma Management
- Available deals in Circle Pharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Circle Pharma Cap Table and Funding History by Share Class and Liquidity Preferences
- Circle Pharma Revenue and Financials
- Circle Pharma Highlights
- Circle Pharma Business Model
- Circle Pharma Risk Factors
- Circle Pharma Research Report from SACRA Research
Trading Circle Pharma Stock
How to invest in Circle Pharma stock?
Accredited investors can buy pre-IPO stock in companies like Circle Pharma through EquityZen funds. These investments are made available by existing Circle Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Circle Pharma stock?
Shareholders can sell their Circle Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 480K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 56K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
